Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS)
CNY 29.08
(-0.55%)
CNY 29.08
(-0.55%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 318.21 Million CNY | 3829.97% |
| 2022 | 4.86 Million CNY | 105.84% |
| 2021 | -83.29 Million CNY | 61.77% |
| 2020 | -217.88 Million CNY | -227.08% |
| 2019 | 171.45 Million CNY | -59.32% |
| 2018 | 421.45 Million CNY | -4.4% |
| 2017 | 440.86 Million CNY | 67.38% |
| 2016 | 263.38 Million CNY | -27.79% |
| 2015 | 364.72 Million CNY | 36.92% |
| 2014 | 266.37 Million CNY | -22.89% |
| 2013 | 345.44 Million CNY | 51.54% |
| 2012 | 227.94 Million CNY | 24.46% |
| 2011 | 183.15 Million CNY | 27.1% |
| 2010 | 144.09 Million CNY | 64.74% |
| 2009 | 87.47 Million CNY | 93.92% |
| 2008 | 45.1 Million CNY | 1182.04% |
| 2007 | 3.51 Million CNY | 109.48% |
| 2006 | -37.11 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 81.64 Million CNY | 45.86% |
| 2024 Q2 | 36.7 Million CNY | -55.04% |
| 2024 Q3 | 112 Million CNY | 205.17% |
| 2023 Q1 | 32.94 Million CNY | -36.74% |
| 2023 Q3 | 79.19 Million CNY | 27.15% |
| 2023 FY | 191.22 Million CNY | 3829.97% |
| 2023 Q4 | 55.97 Million CNY | -29.32% |
| 2023 Q2 | 62.28 Million CNY | 89.08% |
| 2022 FY | 4.86 Million CNY | 105.84% |
| 2022 Q4 | 52.07 Million CNY | 1296.73% |
| 2022 Q3 | -4.35 Million CNY | 82.35% |
| 2022 Q2 | -24.64 Million CNY | -46.48% |
| 2022 Q1 | -16.82 Million CNY | -2090.4% |
| 2021 Q3 | -36.05 Million CNY | -187.66% |
| 2021 Q2 | 41.12 Million CNY | 183.0% |
| 2021 Q1 | -49.55 Million CNY | 72.79% |
| 2021 FY | -83.29 Million CNY | 61.77% |
| 2021 Q4 | 845.35 Thousand CNY | 102.34% |
| 2020 Q2 | 69.96 Million CNY | 161.29% |
| 2020 Q3 | 23.2 Million CNY | -66.83% |
| 2020 Q4 | -182.09 Million CNY | -884.76% |
| 2020 FY | -217.88 Million CNY | -227.08% |
| 2020 Q1 | -114.14 Million CNY | -155.96% |
| 2019 Q2 | 87.94 Million CNY | 211.01% |
| 2019 FY | 171.45 Million CNY | -59.32% |
| 2019 Q4 | 203.97 Million CNY | 332.72% |
| 2019 Q3 | 47.13 Million CNY | -46.4% |
| 2019 Q1 | -79.22 Million CNY | 0.0% |
| 2018 FY | 421.45 Million CNY | -4.4% |
| 2017 FY | 440.86 Million CNY | 67.38% |
| 2016 FY | 263.38 Million CNY | -27.79% |
| 2015 FY | 364.72 Million CNY | 36.92% |
| 2014 FY | 266.37 Million CNY | -22.89% |
| 2013 Q1 | 58.6 Million CNY | 75.56% |
| 2013 Q2 | 74.64 Million CNY | 27.38% |
| 2013 Q3 | 76.61 Million CNY | 2.64% |
| 2013 FY | 345.44 Million CNY | 51.54% |
| 2012 Q2 | 46.17 Million CNY | -32.44% |
| 2012 FY | 227.94 Million CNY | 24.46% |
| 2012 Q4 | 33.38 Million CNY | -58.3% |
| 2012 Q3 | 80.05 Million CNY | 73.37% |
| 2012 Q1 | 68.34 Million CNY | 74.11% |
| 2011 Q2 | 48.24 Million CNY | 34.51% |
| 2011 Q4 | 39.25 Million CNY | -34.35% |
| 2011 Q1 | 35.86 Million CNY | -19.95% |
| 2011 FY | 183.15 Million CNY | 27.1% |
| 2011 Q3 | 59.79 Million CNY | 23.94% |
| 2010 Q1 | 19.99 Million CNY | 0.0% |
| 2010 Q2 | 35.24 Million CNY | 76.31% |
| 2010 Q4 | 44.8 Million CNY | 1.68% |
| 2010 FY | 144.09 Million CNY | 64.74% |
| 2010 Q3 | 44.06 Million CNY | 25.01% |
| 2009 FY | 87.47 Million CNY | 93.92% |
| 2008 FY | 45.1 Million CNY | 1182.04% |
| 2007 FY | 3.51 Million CNY | 109.48% |
| 2006 FY | -37.11 Million CNY | 0.0% |